- Home
- Products
ZYDELIG (Idelalisib)
ZYDELIG (Idelalisib)
- Medicine Name: Zydelig
- Generic Name: Idelalisib
- Dosage Form & Strength: Tablets: 100 mg, 150 mg
- Manufactured By:Gilead Sciences, Inc.
Zydelig (Idelalisib) is a selective oral phosphoinositide 3-kinase delta (PI3Kδ) inhibitor used in the treatment of hematological malignancies.
Indications:
Zydelig is indicated for use in the treatment of the following:
- Chronic Lymphocytic Leukemia (CLL): Used in combination with rituximab in relapsed CLL for patients who are not suitable for rituximab monotherapy due to comorbidities.
- Follicular Lymphoma (FL): For relapsed cases where patients have received at least two prior systemic therapies.
- Small Lymphocytic Lymphoma (SLL): Indicated in patients who have relapsed after two or more systemic therapies.
Recommended Dosage:
Typically prescribed as 150 mg taken orally twice daily. The dosage may be adjusted based on patient tolerance and adverse reactions. Treatment continues until disease progression or unacceptable toxicity occurs.
Serious and potentially fatal hepatotoxicity, colitis, pneumonitis, and intestinal perforation have been reported. Monitor liver function and respiratory symptoms closely.
Infections (including opportunistic infections such as PJP) may occur. Prophylaxis and regular clinical assessments are recommended.
Severe diarrhea and colitis can arise during treatment. Discontinue Zydelig if severe gastrointestinal symptoms are present.
Avoid use in pregnancy; Zydelig may harm the unborn baby. Women of childbearing potential must use effective contraception during and for 1 month after treatment.
Do not breastfeed while taking Zydelig and for at least 1 month after the last dose.
Required Documents for Import to India:
- A valid prescription from a qualified oncologist
- Diagnostic test reports supporting indication
- Government-issued photo ID of the patient
Order Confirmation:
Orders are processed only upon receipt of the above documents, and if necessary, an import permit.
GlobalRareMeds can source Zydelig (Idelalisib) 100 mg and 150 mg tablets from authorized distributors in the USA, Canada, Europe, and Australia.
- Medicines are dispatched directly from our Fulfillment Center in Ambernath, Thane District.
- Dispensing is handled by licensed pharmacists after validation of prescriptions.
- Available in all major Indian cities including Mumbai, Delhi, Bangalore, Chennai, Kolkata, Ahmedabad, Hyderabad, Pune, Jaipur, and across SAARC and Gulf countries.
📞 Call / WhatsApp: +91-99675 15602
📧 Email: info@globalraremeds.com
What is the generic name of Zydelig?
Idelalisib
Who manufactures Zydelig?
Gilead Sciences, Inc.
Is Zydelig approved by the FDA?
Yes, Zydelig received FDA approval on July 23, 2014.
What dosage forms is Zydelig available in?
Zydelig is available as oral tablets in 100 mg and 150 mg strengths.
What are the common side effects of Zydelig?
Common adverse effects may include:
- Diarrhea, fever, nausea
- Fatigue, cough, abdominal pain
- Rash, pneumonia, elevated liver enzymes
Is Zydelig available in India?
Zydelig is not locally marketed in India but can be legally imported through GlobalRareMeds under named-patient import regulations with valid documentation.
How much does Zydelig cost in India?
The price of Zydelig 100 mg or 150 mg may vary. To get the latest pricing, contact us on +91-99675 15602 or email info@globalraremeds.com.
Can Zydelig be made available outside India?
Yes. GlobalRareMeds facilitates legal access to Zydelig in countries across South Asia, the Middle East, and select global regions, depending on local regulations.
How should Zydelig be stored?
Store Zydelig tablets at 20°C to 25°C (68°F to 77°F), protected from moisture and heat. Keep in the original packaging.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
